Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
1.650
-0.050 (-2.94%)
At close: Mar 28, 2025, 4:00 PM
1.700
+0.050 (3.03%)
After-hours: Mar 28, 2025, 7:54 PM EDT
Cassava Sciences Employees
Cassava Sciences had 30 employees as of December 31, 2024. The number of employees increased by 1 or 3.45% compared to the previous year.
Employees
30
Change (1Y)
1
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$811,400
Market Cap
79.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SAVA News
- 4 days ago - Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug - Reuters
- 5 days ago - Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop - Benzinga
- 5 days ago - Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data - GlobeNewsWire
- 27 days ago - Cassava Sciences Reports 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm - PRNewsWire
- 7 weeks ago - SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 7 weeks ago - Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - PRNewsWire
- 2 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PRNewsWire